Area of research
Physiology · Psychiatry and Mental health
Research interest
Research interests include Alzheimer's disease research and treatments, Dementia and Cognitive Impairment Research, Down syndrome and intellectual disability research, and Amyotrophic Lateral Sclerosis Research.
Depressive Symptoms and Amyloid Pathology
Plasma p‐tau212 as a biomarker of sporadic and Down syndrome Alzheimer's disease
Association of Plasma Phosphorylated Tau 217 With Clinical Deterioration Across Alzheimer Disease Stages
High‐frequency oscillations >250 Hz in people with Down syndrome and associated Alzheimer's disease dementia
Proteomic analysis of Down syndrome cerebrospinal fluid compared to late-onset and autosomal dominant Alzheimer´s disease
Body mass index and blood volume influence plasma biomarkers and positron emission tomography classification in preclinical Alzheimer's disease
Apolipoprotein E and Alzheimer's disease pathology in a diverse autopsy study
Diagnostic Accuracy of a Plasma Phosphorylated Tau 217 Immunoassay for Alzheimer Disease Pathology
APOE4 homozygosity represents a distinct genetic form of Alzheimer’s disease
Plasma extracellular vesicle tau and TDP-43 as diagnostic biomarkers in FTD and ALS
Diagnosis of Alzheimer’s disease using plasma biomarkers adjusted to clinical probability
Demographic, clinical, biomarker, and neuropathological correlates of posterior cortical atrophy: an international cohort study and individual participant data meta-analysis
Alzheimer Dementia Among Individuals With Down Syndrome
Age of Alzheimer's disease diagnosis in people with Down syndrome and associated factors: Results from the Horizon 21 European Down syndrome consortium
Adapting prescribing criteria for amyloid‐targeted antibodies for adults with Down syndrome
The neutrophil to lymphocyte ratio associates with markers of Alzheimer’s disease pathology in cognitively unimpaired elderly people
Down Syndrome Biobank Consortium: A perspective
Blood biomarkers in Down syndrome: Facilitating Alzheimer's disease detection and monitoring
Association of biological sex with clinical outcomes and biomarkers of Alzheimer’s disease in adults with Down syndrome
Plasma and cerebrospinal fluid glial fibrillary acidic protein levels in adults with Down syndrome: a longitudinal cohort study
Genome-wide structural variant analysis identifies risk loci for non-Alzheimer’s dementias
Basal forebrain atrophy along the Alzheimer's disease continuum in adults with Down syndrome
Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum
Genome-wide meta-analysis for Alzheimer’s disease cerebrospinal fluid biomarkers
Conducting clinical trials in persons with Down syndrome: summary from the NIH INCLUDE Down syndrome clinical trials readiness working group
Alzheimer's disease research progress in the Mediterranean region: The Alzheimer's Association International Conference Satellite Symposium
Alzheimer's disease associated with Down syndrome: a genetic form of dementia
Opportunities, barriers, and recommendations in Down syndrome research
Association of Apolipoprotein E ɛ4 Allele With Clinical and Multimodal Biomarker Changes of Alzheimer Disease in Adults With Down Syndrome
Phosphorylated tau181 in plasma as a potential biomarker for Alzheimer’s disease in adults with Down syndrome